Inositol monophosphate phosphatase genes of Mycobacterium tuberculosis

BMC Microbiology

Volumn 10, Issue , 2010, Pages

  Movahedzadeh, Farahnaz ^a,f   Wheeler, Paul R ^b   Dinadayala, Premkumar ^c   Av Gay, Yossef ^d   Parish, Tanya ^e   Daffé, Mamadou ^c   Stoker, Neil G ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

^b VETERINARY LABORATORIES AGENCY   (United Kingdom)

^c INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^f UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CYSQ BACTERIAL PROTEIN; GLYCOLIPID; IMPA BACTERIAL PROTEIN; INOSITOL PHOSPHATE; LIPOARABINOMANNAN; LIPOMANNAN; MANNOSIDE; MYCOTHIOL; MYOINOSITOL 1 PHOSPHATE SYNTHASE; PHOSPHATASE; PHOSPHATIDYLINOSITOL; PORIN; SUHB BACTERIAL PROTEIN; THIOL PROTEINASE; UNCLASSIFIED DRUG; CELL EXTRACT; INOSITOL; LIPOPOLYSACCHARIDE; MYO INOSITOL 1 (OR 4) MONOPHOSPHATASE; MYO-INOSITOL-1 (OR 4)-MONOPHOSPHATASE; PHOSPHATIDYLINOSITOL MANNOSIDE;

ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL STRAIN; CONTROLLED STUDY; DIPLOIDY; ENZYME ACTIVITY; GENE EXPRESSION; GENE ISOLATION; GENE MUTATION; GENE SWITCHING; GENE SYNTHESIS; GENETIC ANALYSIS; GENOME; MUTAGENESIS; MUTANT; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; TRANS ISOMER; AMINO ACID SEQUENCE; BIOLOGY; CHEMISTRY; ENZYMOLOGY; GENETICS; METABOLISM; MOLECULAR GENETICS; MUTATION; SEQUENCE ALIGNMENT; SITE DIRECTED MUTAGENESIS;

CORYNEBACTERINEAE; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS;

AMINO ACID SEQUENCE; BACTERIAL PROTEINS; CELL EXTRACTS; COMPUTATIONAL BIOLOGY; GENE EXPRESSION; INOSITOL; LIPOPOLYSACCHARIDES; METABOLIC NETWORKS AND PATHWAYS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; MUTATION; MYCOBACTERIUM TUBERCULOSIS; PHOSPHATIDYLINOSITOLS; PHOSPHORIC MONOESTER HYDROLASES; SEQUENCE ALIGNMENT;

EID: 77949299013     PISSN: 14712180     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-10-50     Document Type: Article

References (55)

1. WHO, http://www.who.int/tb/publications/global-report/2009/pdf/full- report.pdf
2. Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Directly observed short-course therapy. C Dye GP Garnett K Sleeman BG Williams, Lancet 1998 352 9144 1886 1891 10.1016/S0140-6736(98)03199-7 9863786
3. Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. MA Espinal A Laszlo L Simonsen F Boulahbal SJ Kim A Reniero S Hoffner HL Rieder N Binkin C Dye, et al. N Engl J Med 2001 344 17 1294 1303 10.1056/NEJM200104263441706 11320389
4. XDR tuberculosis: an indicator of public-health negligence. A Van Rie D Enarson, Lancet 2006 368 9547 1554 1556 10.1016/S0140-6736(06)69575-5 17084741
5. The envelope layers of mycobacteria with reference to their pathogenicity. M Daffe P Draper, Adv Microb Physiol 1998 39 131 203 10.1016/S0065-2911(08)60016-8 9328647
6. Mycobacteriumtuberculosis cell envelope. RE Lee PJ Brennan GS Besra, Curr Top Microbiol Immunol 1996 215 1 27 8791707
7. Genetics of drug resistance in Mycobacterium tuberculosis. Y Zhang A Telenti, Molecular genetics of mycobacteria Washington, D.C.: ASM Press, Hatfull GF, Jacobs WR Jr, 2000 235 254
8. Phosphatidylinositol is an essential phospholipid of mycobacteria. M Jackson DC Crick PJ Brennan, J Biol Chem 2000 275 39 30092 30099 10.1074/jbc.M004658200 10889206
9. Lipoarabinomannan from Mycobacterium tuberculosis induces the production of tumour necrosis factor from human and murine macrophages. C Moreno J Taverne A Mehlert CA Bate RJ Brealey A Meager GA Rook JH Playfair, Clin Exp Immunol 1989 76 2 240 245 2503277
10. Induction of inducible nitric oxide synthase-NO* by lipoarabinomannan of Mycobacterium tuberculosis is mediated by MEK1-ERK, MKK7-JNK, and NF-kappaB signaling pathways. ED Chan KR Morris JT Belisle P Hill LK Remigio PJ Brennan DW Riches, Infect Immun 2001 69 4 2001 2010 10.1128/IAI.69.4.2001-2010.2001 11254551
11. Effect of Mycobacterium tuberculosis and its components on macrophages and the release of matrix metalloproteinases. JC Chang A Wysocki KM Tchou-Wong N Moskowitz Y Zhang WN Rom, Thorax 1996 51 3 306 311 10.1136/thx.51.3.306 8779137
12. Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication by transcriptional activation at the long terminal repeat. Y Zhang K Nakata M Weiden WN Rom, J Clin Invest 1995 95 5 2324 2331 10.1172/JCI117924 7738195
13. Mycobacterium tuberculosis mannose-capped lipoarabinomannan can induce NF-kappaB-dependent activation of human immunodeficiency virus type 1 long terminal repeat in T cells. R Bernier B Barbeau M Olivier MJ Tremblay, J Gen Virol 1998 79 Pt 6 1353 1361 9634075
14. Immunoglobulin G subclass responses to mycobacterial lipoarabinomannan in HIV-infected and non-infected patients with tuberculosis. CT Da Costa S Khanolkar-Young AM Elliott KM Wasunna KP McAdam, Clin Exp Immunol 1993 91 1 25 29 8419082
15. Detection of anti-lipoarabinomannan antibodies for the diagnosis of active tuberculosis. R Del Prete V Picca A Mosca M D'Alagni G Miragliotta, Int J Tuberc Lung Dis 1998 2 2 160 163 9562127
16. Identification of phosphatidylinositol mannoside as a mycobacterial adhesin mediating both direct and opsonic binding to nonphagocytic mammalian cells. HC Hoppe BJ de Wet C Cywes M Daffe MR Ehlers, Infect Immun 1997 65 9 3896 3905 9284169
17. Different Toll-like receptor agonists induce distinct macrophage responses. BW Jones TK Means KA Heldwein MA Keen PJ Hill JT Belisle MJ Fenton, J Leukoc Biol 2001 69 6 1036 1044 11404392
18. Acylation state of the phosphatidylinositol mannosides from Mycobacterium bovis bacillus Calmette Guerin and ability to induce granuloma and recruit natural killer T cells. M Gilleron C Ronet M Mempel B Monsarrat G Gachelin G Puzo, J Biol Chem 2001 276 37 34896 34904 10.1074/jbc.M103908200 11441009
19. Thiols of intracellularpathogens. Identification of ovothiol A in Leishmaniadonovani and structural analysis of a novel thiol from Mycobacterium bovis. HS Spies DJ Steenkamp, Eur J Biochem 1994 224 1 203 213 10.1111/j.1432-1033.1994.tb20013.x 8076641
20. The structure of U17 isolated from Streptomyces clavuligerus and its properties as an antioxidant thiol. GL Newton CA Bewley TJ Dwyer R Horn Y Aharonowitz G Cohen J Davies DJ Faulkner RC Fahey, Eur J Biochem 1995 230 2 821 825 10.1111/j.1432-1033.1995.0821h.x 7607257
21. The mshA gene encoding the glycosyltransferase of mycothiol biosynthesis is essential in Mycobacterium tuberculosis Erdman. N Buchmeier RC Fahey, FEMS Microbiol Lett 2006 264 1 74 79 10.1111/j.1574-6968.2006.00441.x 17020551
22. Mycothiol is essential for growth of Mycobacterium tuberculosis Erdman. D Sareen GL Newton RC Fahey NA Buchmeier, J Bacteriol 2003 185 22 6736 6740 10.1128/JB.185.22.6736-6740.2003 14594852
23. The Mycobacterium tuberculosis ino1 gene is essential for growth and virulence. F Movahedzadeh DA Smith RA Norman P Dinadayala J Murray-Rust DG Russell SL Kendall SC Rison MS McAlister GJ Bancroft, et al. Mol Microbiol 2004 51 4 1003 1014 10.1046/j.1365-2958.2003.03900.x 14763976
24. A Mycobacterium smegmatis mutant with a defective inositol monophosphate phosphatase gene homolog has altered cell envelope permeability. T Parish J Liu H Nikaido NG Stoker, J Bacteriol 1997 179 24 7827 7833 9401044
25. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. SF Altschul TL Madden AA Schaffer J Zhang Z Zhang W Miller DJ Lipman, Nucleic Acids Res 1997 25 17 3389 3402 10.1093/nar/25.17.3389 9254694
26. Use of a flexible cassette method to generate a double unmarked Mycobacterium tuberculosis tlyA plcABC mutant by gene replacement. T Parish NG Stoker, Microbiology 2000 146 Pt 8 1969 1975 10931901
27. Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. JC Betts PT Lukey LC Robb RA McAdam K Duncan, Mol Microbiol 2002 43 3 717 731 10.1046/j.1365-2958.2002. 02779.x 11929527
28. Differential expression of 10 sigma factor genes in Mycobacterium tuberculosis. R Manganelli E Dubnau S Tyagi FR Kramer I Smith, Mol Microbiol 1999 31 2 715 724 10.1046/j.1365-2958.1999.01212.x 10027986
29. A simple specific spray for the detection of phospholipids on thin layer chromatography. JCF Dittmer RL Lester, Journal of Lipid Research 1964 5 126 127
30. Gas-liquid chromatography of trimethylsilyl derivatives of sugars and related substances. CC Sweeley R Bentley M Makita WW Wells, J Am Chem Soc 1963 85 2497 2507 10.1021/ja00899a032
31. Mycothiol biosynthesis and metabolism. Cellular levels of potential intermediates in the biosynthesis and degradation of mycothiol in mycobacterium smegmatis. SJ Anderberg GL Newton RC Fahey, J Biol Chem 1998 273 46 30391 30397 10.1074/jbc.273.46.30391 9804803
32. Distribution of thiols in microorganisms: mycothiol is a major thiol in most actinomycetes. GL Newton K Arnold MS Price C Sherrill SB Delcardayre Y Aharonowitz G Cohen J Davies RC Fahey C Davis, J Bacteriol 1996 178 7 1990 1995 8606174
33. Characterization and regulation of inositol monophosphatase activity in Mycobacterium smegmatis. J Nigou GS Besra, Biochem J 2002 361 Pt 2 385 390 11772411
34. Structural analysis of inositol monophosphatase complexes with substrates. R Bone L Frank JP Springer SJ Pollack SA Osborne JR Atack MR Knowles G McAllister CI Ragan HB Broughton, et al. Biochemistry 1994 33 32 9460 9467 10.1021/bi00198a011 8068620
35. Decipheringthe biology of Mycobacterium tuberculosis from the complete genome sequence. ST Cole R Brosch J Parkhill T Garnier C Churcher D Harris SV Gordon K Eiglmeier S Gas CE Barry al textitet, Nature 1998 393 6685 537 544 10.1038/31159 9634230
36. A mutation that enhances synthesis of sigma 32 and suppresses temperature-sensitive growth of the rpoH15 mutant of Escherichia coli. R Yano H Nagai K Shiba T Yura, J Bacteriol 1990 172 4 2124 2130 2138605
37. Suppressors of the secY24 mutation: identification and characterization of additional ssy genes in Escherichia coli. K Shiba K Ito T Yura, J Bacteriol 1986 166 3 849 856 3011749
38. Analysis of an Escherichia coli dnaB temperature-sensitive insertion mutation and its cold-sensitive extragenic suppressor. SF Chang D Ng L Baird C Georgopoulos, J Biol Chem 1991 266 6 3654 3660 1847383
39. Lethal double-stranded RNA processing activity of ribonuclease III in the absence of suhB protein of Escherichia coli. T Inada Y Nakamura, Biochimie 1995 77 4 294 302 10.1016/0300-9084(96)88139-9 8589060
40. Overexpression, purification, and analysis of complementation behavior of E. coli SuhB protein: comparison with bacterial and archaeal inositol monophosphatases. L Chen MF Roberts, Biochemistry 2000 39 14 4145 4153 10.1021/bi992424f 10747806
41. Purification and biochemical characterization of Mycobacterium tuberculosis SuhB, an inositol monophosphatase involved in inositol biosynthesis. J Nigou LG Dover GS Besra, Biochemistry 2002 41 4392 4398 10.1021/bi0160056 11914086
42. cysQ, a gene neededfor cysteine synthesis in Escherichia coli K-12 only during aerobic growth. AF Neuwald BR Krishnan I Brikun S Kulakauskas K Suziedelis T Tomcsanyi TS Leyh DE Berg, J Bacteriol 1992 174 2 415 425 1729235
43. The PROSITE database, its status in 1999. K Hofmann P Bucher L Falquet A Bairoch, Nucleic Acids Res 1999 27 1 215 219 10.1093/nar/27.1.215 9847184
44. The MspA porin promotes growth and increases antibiotic susceptibility of both Mycobacterium bovis BCG and Mycobacterium tuberculosis. C Mailaender N Reiling H Engelhardt S Bossmann S Ehlers M Niederweis, Microbiology 2004 150 Pt 4 853 864 10.1099/mic.0.26902-0 15073295
45. Cloning of the mspA gene encoding a porin from Mycobacterium smegmatis. M Niederweis S Ehrt C Heinz U Klocker S Karosi KM Swiderek LW Riley R Benz, Mol Microbiol 1999 33 5 933 945 10.1046/j.1365-2958.1999.01472.x 10476028
46. Probing the role of metal ions in the mechanism of inositol monophosphatase by site-directed mutagenesis. SJ Pollack MR Knowles JR Atack HB Broughton CI Ragan S Osborne G McAllister, Eur J Biochem 1993 217 1 281 287 10.1111/j.1432-1033.1993.tb18244.x 8223565
47. Genes required for mycobacterial growth defined by high density mutagenesis. CM Sassetti DH Boyd EJ Rubin, Mol Microbiol 2003 48 1 77 84 10.1046/j.1365-2958.2003.03425.x 12657046
48. Rv2131c gene product: an unconventional enzyme that is both inositol monophosphatase and fructose-1,6-bisphosphatase. X Gu M Chen H Shen X Jiang Y Huang H Wang, Biochem Biophys Res Commun 2006 339 3 897 904 10.1016/j.bbrc.2005. 11.088 16325768
49. Rv2131c from Mycobacterium tuberculosis is a CysQ 3'-phosphoadenosine-5'- phosphatase. SK Hatzios AT Iavarone CR Bertozzi, Biochemistry 2008 47 21 5823 5831 10.1021/bi702453s 18454554
50. Gene expression profile of Mycobacterium tuberculosis in a non-replicating state. DG Muttucumaru G Roberts J Hinds RA Stabler T Parish, Tuberculosis (Edinb) 2004 84 3-4 239 246 10.1016/j.tube.2003.12.006 15207493
51. The anaerobic ribonucleotide reductase from Escherichia coli. The small protein is an activating enzyme containing a [4fe-4s](2+) center. J Tamarit E Mulliez C Meier A Trautwein M Fontecave, J Biol Chem 1999 274 44 31291 31296 10.1074/jbc.274.44.31291 10531327
52. Genetic evidence identifying the true gluconeogenic fructose-1,6- bisphosphatase in Thermococcus kodakaraensis and other hyperthermophiles. T Sato H Imanaka N Rashid T Fukui H Atomi T Imanaka, J Bacteriol 2004 186 17 5799 5807 10.1128/JB.186.17.5799-5807.2004 15317785
53. The Mycobacterium tuberculosis Rv1099c gene encodes a GlpX-like class II fructose 1,6-bisphosphatase. F Movahedzadeh SC Rison PR Wheeler SL Kendall TJ Larson NG Stoker, Microbiology 2004 150 Pt 10 3499 3505 10.1099/mic.0.27204-0 15470127
54. Site-directed mutagenesis of the 19-kilodalton lipoprotein antigen reveals No essential role for the protein in the growth and virulence of Mycobacterium intracellulare. E Mahenthiralingam BI Marklund LA Brooks DA Smith GJ Bancroft RW Stokes, Infect Immun 1998 66 8 3626 3634 9673242
55. High-resolution structure of myo-inositol monophosphatase, the putative target of lithium therapy. R Gill F Mohammed R Badyal L Coates P Erskine D Thompson J Cooper M Gore S Wood, Acta Cryst 2005 D61 545 555